Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Researchers analyzed more than 350 studies to estimate the prevalence of hepatitis B among people with HIV around the world.
This finding suggests that the HIV-preventing vaginal ring that awaits regulatory approval may achieve widespread use.
This PrEP dosing strategy involves taking doses of Truvada only during the days surrounding sex.
Men who have sex with men are at higher risk for the disease, which is driven by human papillomavirus.
The strain was associated with a high viral load and low CD4 counts before men started treatment.
Factors associated with a higher risk of impairment include depression, poor adherence to antiretrovirals and opportunistic infections.
People who start treatment within nine days, compared with more than 90, may be less likely to be in medical care one year later.
That is according to a meta-analysis including nearly 500 people.
The Mosaico study will enroll gay and bisexual men and transgender people at significant risk for the virus.
Calling all U.S. cisgender gay and bi men and trans and gender nonconforming people at risk for the virus.
Nonetheless, the United Kingdom recorded the lowest rate of new HIV cases in nearly 20 years.
However, an analysis of Swiss people with HIV found no significant change in the suicide rate in more recent years.
Swiss researchers analyzed shifts in kidney function among those switching from the old form of the HIV medication to the new one.
On-demand PrEP is taken only during the days surrounding sex.
Researchers conducted an analysis of hep C treatment outcomes in those also living with HIV in Western nations.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.